EMF Mitigation Symptom Ratings: Phase 1 Pilot Study
Phase 1 Formal Study using Mainstream Methods: n=10
A closer look at reducing EMF-related symptoms with FLFE
Electromagnetic Hypersensitivity, also known as EMF Sensitivity, is a condition with symptoms, such as skin problems, and nervous system issues often triggered by exposure to EMFs from our environment. These symptoms can be similar to those experienced by people with chemical sensitivities.
Some experts recommend limiting one’s exposure to EMF, but in our technology-driven world, it is becoming harder to avoid EMFs. This is why EMF mitigation is so important.
FLFE offers an EMF mitigation service to help ease these symptoms and allow our bodies the opportunity to better adapt to these fields. This research study aims to build on previous research and to further explore and validate the effects of this service.
Study Details
The ‘Why’
FLFE’s goals were threefold:
- To complete initial measures of FLFE’s EMF mitigation effects on a small sample of individuals who self-identify as highly EMF sensitive.
- To identify ways to improve and upgrade the current FLFE’s EMF mitigation capacity.
- To inform and justify future replication of the same research phase with a larger sample size exploring FLFE’s EMF mitigation effects.
The ‘Who’
10 self-identified highly EMF-sensitive individuals with no prior exposure to the FLFE service.
The ‘How’
Participants filled out three questionnaires on the intensity and frequency of 30 most-common EMF symptoms over a period of 90 days. Upon completing the baseline questionnaire at Day 0, the FLFE service was activated on the property and a portable object (i.e., a crystal that was mailed to each participant) (or a mobile phone) of each participant. At Day 45, participants filled out a follow-up survey and at Day 90, participants filled out a final survey.
The ‘When’
Data collection occurred between March 2022 and September 2022.
The ‘Where’
Data collection occurred remotely (i.e., in the home/personal environment of each participant)
Statistical Significance: Average Symptom Intensity effect over the three administrations was significant at p<0.0005; Average Symptom Frequency effect over the three administrations was p<0.005).
Experience FLFE
If you’re ready to experience FLFE and EMF Mitigation first-hand subscribe below or experience the 15-day trial,
with no cancellation or payment information required.
Free 15-Day Trial. No Credit Card Needed
Explore & Experience the FLFE Products
